Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Hassan Rezaei Kalantari"'
Autor:
Marc Peeters, Christian Rolfo, Guy Van Camp, Ken Op de Beeck, Erik Fransen, Patrick Pauwels, Karen Zwaenepoel, Hassan Rezaei Kalantari, Koen Hendrickx, Jochen Decaestecker, Wim Demey, Willem Lybaert, Greetje Vanhoutte, Katleen Janssens
Copy number alteration (CNA) profile of patient 24 based on shallow whole-genome sequencing (sWGS) of the baseline cfDNA sample.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7354645a32e29778894d373113baf66
https://doi.org/10.1158/1078-0432.22725410
https://doi.org/10.1158/1078-0432.22725410
Autor:
Marc Peeters, Christian Rolfo, Guy Van Camp, Ken Op de Beeck, Erik Fransen, Patrick Pauwels, Karen Zwaenepoel, Hassan Rezaei Kalantari, Koen Hendrickx, Jochen Decaestecker, Wim Demey, Willem Lybaert, Greetje Vanhoutte, Katleen Janssens
Supplementary data on the comparison of anti-EGFR therapy to anti-VEGF therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63a031a57068066fdb7ac1bdc4c2cfe6
https://doi.org/10.1158/1078-0432.22725431
https://doi.org/10.1158/1078-0432.22725431
Autor:
Marc Peeters, Christian Rolfo, Guy Van Camp, Ken Op de Beeck, Erik Fransen, Patrick Pauwels, Karen Zwaenepoel, Hassan Rezaei Kalantari, Koen Hendrickx, Jochen Decaestecker, Wim Demey, Willem Lybaert, Greetje Vanhoutte, Katleen Janssens
Median methylation ratio.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22ef32ac6c5566ec9915af8d5de4758c
https://doi.org/10.1158/1078-0432.22725419
https://doi.org/10.1158/1078-0432.22725419
Autor:
Marc Peeters, Christian Rolfo, Guy Van Camp, Ken Op de Beeck, Erik Fransen, Patrick Pauwels, Karen Zwaenepoel, Hassan Rezaei Kalantari, Koen Hendrickx, Jochen Decaestecker, Wim Demey, Willem Lybaert, Greetje Vanhoutte, Katleen Janssens
Normalized methylation ratio.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06b5242de73f998bb4cb6c0ebc802f55
https://doi.org/10.1158/1078-0432.22725416
https://doi.org/10.1158/1078-0432.22725416
Autor:
Marc Peeters, Christian Rolfo, Guy Van Camp, Ken Op de Beeck, Erik Fransen, Patrick Pauwels, Karen Zwaenepoel, Hassan Rezaei Kalantari, Koen Hendrickx, Jochen Decaestecker, Wim Demey, Willem Lybaert, Greetje Vanhoutte, Katleen Janssens
Follow-up of patients during treatment using methylated ctDNA.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40ddbadaddbe765a185d6551cad251d4
https://doi.org/10.1158/1078-0432.22725413
https://doi.org/10.1158/1078-0432.22725413
Autor:
Marc Peeters, Christian Rolfo, Guy Van Camp, Ken Op de Beeck, Erik Fransen, Patrick Pauwels, Karen Zwaenepoel, Hassan Rezaei Kalantari, Koen Hendrickx, Jochen Decaestecker, Wim Demey, Willem Lybaert, Greetje Vanhoutte, Katleen Janssens
Kaplan Meier curve for overall survival.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1455b0219158fd673a408c41e20c2abd
https://doi.org/10.1158/1078-0432.22489798
https://doi.org/10.1158/1078-0432.22489798
Autor:
Marc Peeters, Christian Rolfo, Guy Van Camp, Ken Op de Beeck, Erik Fransen, Patrick Pauwels, Karen Zwaenepoel, Hassan Rezaei Kalantari, Koen Hendrickx, Jochen Decaestecker, Wim Demey, Willem Lybaert, Greetje Vanhoutte, Katleen Janssens
Table S1. Negative control samples used for LOB determination; Table S2. Quality of sequencing of BRAF and RAS genes; Table S3. REMARK checklist; Table S4. Patient characteristics; Table S5. Safety profiles; Table S6. Adverse event data; Table S7. As
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c408ca20213729842632c4d84d501228
https://doi.org/10.1158/1078-0432.22489780
https://doi.org/10.1158/1078-0432.22489780
Autor:
Marc Peeters, Christian Rolfo, Guy Van Camp, Ken Op de Beeck, Erik Fransen, Patrick Pauwels, Karen Zwaenepoel, Hassan Rezaei Kalantari, Koen Hendrickx, Jochen Decaestecker, Wim Demey, Willem Lybaert, Greetje Vanhoutte, Katleen Janssens
1. Eligibility criteria - Inclusion criteria, Exclusion criteria; 2. ddPCR methodology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00ec1fa70dea724e741c546129c37d08
https://doi.org/10.1158/1078-0432.22489783
https://doi.org/10.1158/1078-0432.22489783
Autor:
Marc Peeters, Christian Rolfo, Guy Van Camp, Ken Op de Beeck, Erik Fransen, Patrick Pauwels, Karen Zwaenepoel, Hassan Rezaei Kalantari, Koen Hendrickx, Jochen Decaestecker, Wim Demey, Willem Lybaert, Greetje Vanhoutte, Katleen Janssens
Purpose:Analysis of methylation markers in liquid biopsies is a promising technique for the follow-up of patients with metastatic colorectal cancer (mCRC), because they can be used in all patients, regardless of their mutational status. Therefore, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3a05cedd357a84fdfb395e13f7ca70d
https://doi.org/10.1158/1078-0432.c.6533041.v1
https://doi.org/10.1158/1078-0432.c.6533041.v1
Autor:
Marc Peeters, Christian Rolfo, Guy Van Camp, Ken Op de Beeck, Erik Fransen, Patrick Pauwels, Karen Zwaenepoel, Hassan Rezaei Kalantari, Koen Hendrickx, Jochen Decaestecker, Wim Demey, Willem Lybaert, Greetje Vanhoutte, Katleen Janssens
Kaplan Meier curve for progression free survival.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad2e19a453ec818779496f61cbcb07ae
https://doi.org/10.1158/1078-0432.22489801.v1
https://doi.org/10.1158/1078-0432.22489801.v1